Brady (US:BRC)2025-05-16 11:08Financial Performance - Sales for the third quarter ended April 30, 2025, increased by 11.4% to $382.6 million, compared to $343.4 million in the same quarter last year[3]. - Adjusted Diluted EPS for the third quarter was $1.22, an increase of 11.9% compared to $1.09 in the same quarter last year[6]. - Adjusted Net Income for the third quarter was $58.8 million, up from $52.7 million in the same quarter last year[5]. - For the nine-month period ended April 30, 2025, sales increased by 11.9% to $1.12 billion compared to $998.0 million in the same period last year[7]. - Adjusted Income Before Income Taxes for the nine-month period was $205.4 million, an increase of 10.0% compared to the same period last year[8]. - Adjusted Net Income for the nine months ended April 30, 2025, was $161,098 million, compared to $147,201 million for the same period in 2024, reflecting a 9.4% increase[26]. - Adjusted Diluted EPS for the nine months ended April 30, 2025, was $3.34, compared to $3.03 in the same period of 2024, indicating a 10.3% increase[27]. Shareholder Returns - The Company returned $44.5 million to shareholders through dividends and share repurchases during the quarter[6]. - The Company repurchased 476,000 shares for $33.2 million during the quarter[10]. Guidance and Projections - The Company tightened its Adjusted Diluted EPS guidance for the fiscal year ending July 31, 2025, to a range of $4.48 to $4.63 per share[11]. - Fiscal 2025 guidance for Adjusted Diluted EPS is projected between $4.48 and $4.63, with a GAAP measure expectation of $3.95 to $4.10[28]. - Amortization expense for fiscal 2025 is expected to remain constant at $0.30 per Class A Nonvoting Common Share[28]. - Facility closure and other reorganization costs are projected at $0.15 per Class A Nonvoting Common Share for fiscal 2025[28]. - Non-recurring acquisition-related costs and other expenses are expected to be $0.08 per Class A Nonvoting Common Share for fiscal 2025[28]. Income and Expenses - Income before income taxes for the third quarter increased by 2.1% to $65.7 million compared to $64.4 million in the same quarter last year[4]. - Adjusted Income Before Income Taxes for the three months ended April 30, 2025, was $74.43 million, compared to $66.78 million in the same period of 2024[24]. - The company reported a net income of $139.38 million for the nine months ended April 30, 2025, slightly down from $141.76 million in the same period of 2024[21]. - The company reported a GAAP net income of $52,263 million for Q3 2025, compared to $50,890 million in Q3 2024, a 2.7% increase[26]. - The company incurred $2,947 million in facility closure and reorganization costs for Q3 2025, compared to no such costs in Q3 2024[26]. Cash and Liabilities - The company’s net cash provided by operating activities for the nine months ended April 30, 2025, was $122.87 million, down from $171.09 million in the same period of 2024[21]. - Cash and cash equivalents decreased to $152.15 million as of April 30, 2025, from $250.12 million at the beginning of the period[21]. - Total liabilities increased to $530.56 million as of April 30, 2025, compared to $448.91 million as of July 31, 2024[20]. - The company’s long-term debt increased to $102.82 million as of April 30, 2025, from $90.94 million as of July 31, 2024[20]. - The company’s total stockholders' equity rose to $1.17 billion as of April 30, 2025, up from $1.07 billion as of July 31, 2024[20]. Regional Performance - The Americas & Asia region saw organic sales growth of 5.4%, while Europe & Australia experienced an organic sales decline of 5.4%[3]. - The Americas & Asia segment reported net sales of $253.65 million, up 12.9% year-over-year, while Europe & Australia segment sales increased by 8.7% to $128.94 million[22]. - The company’s segment profit margin for the Americas & Asia was 22.5% for the three months ended April 30, 2025, compared to 22.1% in the same period of 2024[22].